Since both protein kinases are dysregulated in several neurodegenerative diseases (e.g., tauopathies) and in neuropathic pain [20,21], the investigated extract could show therapeutic effects in such disorders through dual inhibition of CDK5 and GSK-3β. The gene discussed is WEE1; the disease is tauopathy.